Literature DB >> 8378084

Regulation of trans-activating capacity of CRE-BPa by phorbol ester tumor promoter TPA.

Y L Zu1, T Maekawa, N Nomura, T Nakata, S Ishii.   

Abstract

CRE-BPa, here designated as CRE-BPa alpha, is a novel member of the CRE (cAMP response element)-binding protein CRE-BP1 family. CRE-BPa alpha has four regions highly homologous to CRE-BP1, including a putative metal finger structure and a DNA-binding domain consisting of a basic amino acid cluster and a leucine zipper. CRE-BPa specifically binds to CRE as a homodimer or heterodimer with c-Jun or CRE-BP1. Here we report three alternative splicing forms of CRE-BPa alpha: two of them, CRE-BPa beta and CRE-BPa gamma, lack the N-terminal 7 and 33 amino acids of CRE-BPa alpha, and the third one CRE-BPa delta, has 16 additional amino acids in the N-terminus and amino acids 156-508 of CRE-BPa alpha. In CAT cotransfection experiments using CV-1 cells, transient expression of each of four CRE-BPa proteins caused a 1.6- to 3.4-fold increase of CRE-dependent transcription, respectively. Interestingly, these weak trans-activating capacities of CRE-BPa proteins were enhanced 2.7- to 3.6-fold by treatment of cells with 12-O-tetradecanoyl-phorbol 13-acetate (TPA). However, CRE-BPa did not affect the TPA-induced and TRE (TPA response element)-dependent transcription. These results indicate that CRE-BPa is a CRE-dependent trans-activator, and that CRE-BPa can confer TPA inducibility on CRE. Thus, CRE-BPa has an unique characteristic of cross-talk between cAMP pathway and TPA pathway.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8378084

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

Review 1.  ATF3 and stress responses.

Authors:  T Hai; C D Wolfgang; D K Marsee; A E Allen; U Sivaprasad
Journal:  Gene Expr       Date:  1999

2.  CREB5 promotes tumor cell invasion and correlates with poor prognosis in epithelial ovarian cancer.

Authors:  Shanyang He; Yalan Deng; Yanbin Liao; Xiaojin Li; Jun Liu; Shuzhong Yao
Journal:  Oncol Lett       Date:  2017-10-20       Impact factor: 2.967

3.  An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors.

Authors:  Beihua Dong; Sanggu Kim; Seunghee Hong; Jaydip Das Gupta; Krishnamurthy Malathi; Eric A Klein; Don Ganem; Joseph L Derisi; Samson A Chow; Robert H Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-18       Impact factor: 11.205

Review 4.  MicroRNA-34/449 family and viral infections.

Authors:  Jianliang Lv; Zhongwang Zhang; Li Pan; Yongguang Zhang
Journal:  Virus Res       Date:  2018-11-06       Impact factor: 3.303

5.  MicroRNA 876-5p modulates EV-A71 replication through downregulation of host antiviral factors.

Authors:  Peng Xu; Hwa Xu; Hsu Sheng Cheng; Han-Hsiang Chan; Robert Y L Wang
Journal:  Virol J       Date:  2020-02-05       Impact factor: 4.099

6.  Epigenetically regulated miR-449a enhances hepatitis B virus replication by targeting cAMP-responsive element binding protein 5 and modulating hepatocytes phenotype.

Authors:  Xiaoyong Zhang; Hongyan Liu; Zhanglian Xie; Wangyu Deng; Chunchen Wu; Bo Qin; Jinlin Hou; Mengji Lu
Journal:  Sci Rep       Date:  2016-05-03       Impact factor: 4.379

7.  Integrated analysis of DNA methylome and transcriptome identified CREB5 as a novel risk gene contributing to recurrent pregnancy loss.

Authors:  Mingming Yu; Guizhen Du; Qiaoqiao Xu; Zhenyao Huang; Xiaomin Huang; Yufeng Qin; Li Han; Yun Fan; Yan Zhang; Xiumei Han; Ziyan Jiang; Yankai Xia; Xinru Wang; Chuncheng Lu
Journal:  EBioMedicine       Date:  2018-08-10       Impact factor: 8.143

8.  CREB5 promotes invasiveness and metastasis in colorectal cancer by directly activating MET.

Authors:  Shuyang Wang; Junfeng Qiu; Lei Liu; Cailin Su; Lu Qi; Chengmei Huang; Xiaoning Chen; Yaxin Zhang; Yaping Ye; Yanqing Ding; Li Liang; Wenting Liao
Journal:  J Exp Clin Cancer Res       Date:  2020-08-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.